SCHEMBL6207031

SCHEMBL6207031

C=C(N)C(=O)OC(=O)c1ccccc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.47
CES1 P23141 1/20 0.47
KMT2A Q03164 4/20 0.45
NPC1 O15118 3/20 0.45
MEN1 O00255 2/20 0.45
RAB9A P51151 2/20 0.45
ALDH1A1 P00352 4/20 0.44
ALOX15 P16050 1/20 0.44
TDP1 Q9NUW8 1/20 0.43
ADRB2 P07550 1/20 0.43
ADRB1 P08588 1/20 0.43
ADRB3 P13945 1/20 0.43
GAA P10253 2/20 0.42
PKM P14618 1/20 0.42
LMNA P02545 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6208654 0.87 CES2 (0.50) CES2CES1KMT2ANPC1MEN1
SCHEMBL8378855 0.81 CES2 (0.62) CES2CES1KMT2ANPC1MEN1
SCHEMBL6207827 0.81 HPGD (0.52) KMT2ANPC1RAB9AALDH1A1ALOX15
Hydrochloric Acid SCHEMBL2145842 0.80 CES2 (0.52) CES2CES1KMT2ANPC1MEN1
SCHEMBL6205116 0.79 NPC1 (0.50) KMT2ANPC1MEN1RAB9AALDH1A1
SCHEMBL6206781 0.79 RAB9A (0.50) CES2CES1KMT2ANPC1MEN1
SCHEMBL29050175 0.79 MAPT (0.44) CES2CES1KMT2ANPC1MEN1
SCHEMBL6205639 0.79 MAPT (0.43) KMT2ANPC1MEN1RAB9AALDH1A1
SCHEMBL6206850 0.79 LMNA (0.46) NPC1RAB9ATDP1GAALMNA
SCHEMBL6208809 0.77 HPGD (0.51) KMT2ANPC1RAB9AALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1532128-A1 INHIBITORS OF HCV NS5B POLYMERASE Pharmacia & Upjohn Company LLC (US) 2005-05-25 EP disclosed
WO-2004002977-A1 INHIBITORS OF HCV NS5B POLYMERASE PHARMACIA & UPJOHN COMPANY LLC (US) 2004-01-08 WO disclosed